Autres langues Anika Therapeutics, Inc.

Actions

ANIK

US0352551081

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 01/05/2024			Varia. 5j.	Varia. 1 janv.
26,49 ^USD	+2,32%		+2,28%	+16,90%

14/03	ANIKA THERAPEUTICS, INC. : Opinion positive de Barrington Research	ZM
13/03	Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024	18/04
Anika to Participate in the 23rd Annual Needham Virtual Healthcare Conference	02/04
Anika: Q4 Earnings Snapshot	13/03
Anika Therapeutics Swings to Q4 Earnings As Revenue Rises; to Cut 9% Workforce	13/03
Anika Therapeutics Guides For FY 2024 Revenue of $168-$173 Million, vs CIQ Analyst Consensus of $179 Million	13/03
Earnings Flash (ANIK) ANIKA THERAPEUTICS Reports Q4 EPS $0.05, vs. Street Est of $-0.23	13/03
Earnings Flash (ANIK) ANIKA THERAPEUTICS Posts Q4 Revenue $43M, vs. Street Est of $41.4M	13/03
Anika Reports Fourth Quarter and Year-End 2023 Financial Results	13/03
Anika Therapeutics, Inc. Provides Earnings Guidance for the Fiscal Year 2024	13/03
Anika Therapeutics, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	13/03
Anika Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	13/03
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	08/03
Activist investor Caligan discloses 9.7% stake in Anika, nominates two director candidates	07/03
Caligan Partners LP Issues Notice of Nominations to Anika Therapeutics, Inc	07/03
Anika to Issue Fourth Quarter and Year-End 2023 Financial Results on Wednesday, March 13, 2024	27/02
Anika Therapeutics, Inc. Announces Board Changes	26/02
Anika Highlights Its Recently Launched IntegrityTM Implant System and RevoMotionTM Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products during the 2024 AAOS Annual Meeting	14/02
Anika Highlights Its Recently Launched Integrity™ Implant System and RevoMotion™ Reverse Shoulder Arthroplasty System Along with Other Key Regenerative Products During the 2024 AAOS Annual Meeting	13/02
Anika Announces First Surgeries Performed using the Integrity Implant System, a Regenerative Hyaluronic Acid-Based Patch System for Rotator Cuff Repairs, Commencing Limited Market Release	29/11
Anika Therapeutics Says Surgeries Using Integrity Implant System Successful	28/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Anika Therapeutics, Inc.

Actions

ANIK

US0352551081

Autres langues

Filtres